U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107087) titled 'A Cluster Randomised Controlled Trial of a Multimodal Integrated Intervention for Kidney Cachexia' on July 30.
Brief Summary: This lay description has been written in conjunction with, and the content approved by our Patient and Public Involvement collaborators.
Patients with kidney cachexia will experience extreme muscle loss, reduced strength and symptoms including fatigue, reduced appetite and lower quality of life. Patients are also at an increased risk of hospitalisation and shortened life expectancy. Previous research suggests that treatments that target several causes of the muscle wasting syndrome (known as cachexia), show b...